Patents by Inventor Christina L. Stallings

Christina L. Stallings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230115208
    Abstract: Described is a composition that includes: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable salt thereof. The composition is useful in the treatment of tuberculosis.
    Type: Application
    Filed: September 14, 2022
    Publication date: April 13, 2023
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20220117968
    Abstract: The present disclosure provides compounds, methods, and compositions which may be used to treat tuberculosis. In some embodiments, these compounds and compositions have a bactericidal property against Mycobacterium tuberculosis (Mtb). Methods of employing such agents are also provided.
    Type: Application
    Filed: July 17, 2018
    Publication date: April 21, 2022
    Inventors: Marvin J. MEYERS, Megh SINGH, Christina L. STALLINGS, Leslie A. WEISS, Scott WILDMAN, Stacy D. ARNETT
  • Patent number: 10945999
    Abstract: The present disclosure provides a combination comprising: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable combination thereof. The combination may be used in the treatment and/or prevention of tuberculosis.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: March 16, 2021
    Assignees: QURETECH BIO AB, WASHINGTON UNIVERSITY IN SAINT LOUIS
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20200352919
    Abstract: Described is a composition that includes: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable salt thereof. The composition is useful in the treatment of tuberculosis.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 12, 2020
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20190091210
    Abstract: The present disclosure provides a combination comprising: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable combination thereof. The combination may be used in the treatment and/or prevention of tuberculosis.
    Type: Application
    Filed: April 7, 2017
    Publication date: March 28, 2019
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten